Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture.
Lysophosphatidic acid (LPA) is a growth factor-like mediator for fibroblasts or smooth muscle cells produced and released by activated platelets. Platelet activation occurs with hepatic necrosis and subsequent liver regeneration and fibrosis. In the fibrosis, hepatic stellate cells proliferate with phenotypic transformation to myofibroblasts. Thus, effects of LPA on proliferation of hepatocytes and stellate cells were investigated. In cultured rat stellate cells, LPA increased DNA synthesis with enhanced MAP kinase activity. Pertussis toxin (PTX) attenuated this mitogenic action. In contrast, LPA decreased DNA synthesis by cultured rat hepatocytes induced by hepatocyte growth factor (HGF) or epidermal growth factor (EGF) without affecting protein synthesis. Enhanced MAP kinase activity by HGF or EGF was not changed by LPA. This anti-mitogenic action was attenuated by PTX. TGFbeta level in the medium was less than the level effective for inhibiting the DNA synthesis in the presence of LPA. Our results suggest that LPA might affect proliferation of hepatocytes and stellate cells in liver diseases complicating platelet activation.
Ikeda
H
H
First Department of Internal Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113, Japan.
Yatomi
Y
Y
Yanase
M
M
Satoh
H
H
Nishihara
A
A
Kawabata
M
M
Fujiwara
K
K
D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008246:Lysophospholipids / Q000494:pharmacology*; D008297:Male; D037342:Pertussis Toxin; D015539:Platelet Activation / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D016212:Transforming Growth Factor beta / Q000378:metabolism; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D008246:Lysophospholipids; D016212:Transforming Growth Factor beta; D010566:Virulence Factors, Bordetella; D004815:Epidermal Growth Factor; D017228:Hepatocyte Growth Factor; D004247:DNA; D037342:Pertussis Toxin; D017871:Calcium-Calmodulin-Dependent Protein Kinases